DENVER--(BUSINESS WIRE)--VieCure today announced a new collaboration with Labcorp to provide clinicians greater access to precision oncology decision support. This strategic collaboration will support ...

This understanding is driving a shift from isolated tests to comprehensive diagnostic panels; carefully structured groups of ...

Illumina, Inc. (NASDAQ: ILMN) today announced that reimbursement has been granted for its FDA-approved in vitro diagnostic ...

Therapeutic decision making for patients with advanced non–small cell lung cancer (aNSCLC) includes a growing number of options for genomic, biomarker-guided, targeted therapies. We compared ...

Gone are the days when oncologists reacted to a cancer diagnosis by using the few drugs we had and hoping for the best. We have evolved from being reactive to proactive, primarily due to advances in ...

LONDON--(BUSINESS WIRE)-- Smiths Detection, a global leader in threat detection and security screening technologies, and a business of Smiths Group plc, today announces the launch of the SDX 6040 ...

Autoimmune diseases often present with overlapping, non-specific symptoms that complicate timely diagnosis and treatment. This complexity is magnified for individuals with polyautoimmunity, ...

January 16, 2026 - PRESSADVANTAGE - Parfuse Corporation, a long-established aluminum fabrication and metal joining ...